Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Fabhalta is also approved for paroxysmal nocturnal hemoglobinuria, a rare blood disease
Yusta B, Baggio LL, Estall JL, Koehler JA, Holland DP, et al
In the event of any safety concerns or for any other information about a product please carefully read any instructions provided on the label or packaging and contact the manufacturer
Composition BPC-157: 20 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment Assay development and calibration for quantitative analysis Chromatographic method optimization for impurity profiling Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
See our Back Pain Prevention Strategies for ideas
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
